144 related articles for article (PubMed ID: 11986346)
1. The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter.
Sulzbacher I; Birner P; Trieb K; Pichlbauer E; Lang S
J Clin Pathol; 2002 May; 55(5):381-5. PubMed ID: 11986346
[TBL] [Abstract][Full Text] [Related]
2. Roles of bone morphogenetic protein signaling in osteosarcoma.
Nguyen A; Scott MA; Dry SM; James AW
Int Orthop; 2014 Nov; 38(11):2313-22. PubMed ID: 25209345
[TBL] [Abstract][Full Text] [Related]
3. Expression of bone morphogenetic protein and its receptors in osteosarcoma and malignant fibrous histiocytoma.
Mehdi R; Shimizu T; Yoshimura Y; Gomyo H; Takaoka K
Jpn J Clin Oncol; 2000 Jun; 30(6):272-5. PubMed ID: 10939432
[TBL] [Abstract][Full Text] [Related]
4. Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody.
Yoshikawa H; Rettig WJ; Takaoka K; Alderman E; Rup B; Rosen V; Wozney JM; Lane JM; Huvos AG; Garin-Chesa P
Cancer; 1994 Jan; 73(1):85-91. PubMed ID: 7506120
[TBL] [Abstract][Full Text] [Related]
5. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins in bone tumors.
Yoshikawa H; Nakase T; Myoui A; Ueda T
J Orthop Sci; 2004; 9(3):334-40. PubMed ID: 15168194
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of bone morphogenetic activity in osteosarcoma tissue.
Yoshikawa H; Takaoka K; Masuhara K; Ono K; Sakamoto Y
Cancer; 1988 Feb; 61(3):569-73. PubMed ID: 3422172
[TBL] [Abstract][Full Text] [Related]
8. Expression of bone morphogenetic proteins in human osteogenic and epithelial tumor cells.
Ogose A; Motoyama T; Hotta T; Watanabe H
Pathol Int; 1996 Jan; 46(1):9-14. PubMed ID: 10846544
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD31, Met/hepatocyte growth factor receptor and bone morphogenetic protein in bone metastasis of osteosarcoma.
Arihiro K; Inai K
Pathol Int; 2001 Feb; 51(2):100-6. PubMed ID: 11169148
[TBL] [Abstract][Full Text] [Related]
10. Livin and Bcl-2 expression in high-grade osteosarcoma.
Nedelcu T; Kubista B; Koller A; Sulzbacher I; Mosberger I; Arrich F; Trieb K; Kotz R; Toma CD
J Cancer Res Clin Oncol; 2008 Feb; 134(2):237-44. PubMed ID: 17632732
[TBL] [Abstract][Full Text] [Related]
11. Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9.
Park H; Drevelle O; Daviau A; Senta H; Bergeron E; Faucheux N
Anticancer Drugs; 2013 Mar; 24(3):278-90. PubMed ID: 23262982
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis.
Uozaki H; Horiuchi H; Ishida T; Iijima T; Imamura T; Machinami R
Cancer; 1997 Jun; 79(12):2336-44. PubMed ID: 9191521
[TBL] [Abstract][Full Text] [Related]
13. [A quantitative immunohistochemical analysis of bone morphogenetic protein (BMP) in osteosarcoma of jaw].
Jin Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Sep; 26(5):276-8, 316-7. PubMed ID: 1815858
[TBL] [Abstract][Full Text] [Related]
14. Expression of bone morphogenetic proteins in giant cell tumor of bone.
Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins 1 to 7 in human breast cancer, expression pattern and clinical/prognostic relevance.
Davies SR; Watkins G; Douglas-Jones A; Mansel RE; Jiang WG
J Exp Ther Oncol; 2008; 7(4):327-38. PubMed ID: 19227012
[TBL] [Abstract][Full Text] [Related]
16. Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cells.
Gobbi G; Sangiorgi L; Lenzi L; Casadei R; Canaider S; Strippoli P; Lucarelli E; Ghedini I; Donati D; Fabbri N; Warzecha J; Yeoung C; Helman LJ; Picci P; Carinci P
Int J Oncol; 2002 Jan; 20(1):143-7. PubMed ID: 11743655
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein signaling in musculoskeletal cancer.
Bami M; Mavrogenis AF; Angelini A; Milonaki M; Mitsiokapa E; Stamoulis D; Soucacos PN
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2061-72. PubMed ID: 27043154
[TBL] [Abstract][Full Text] [Related]
18. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
[TBL] [Abstract][Full Text] [Related]
19. Expression of bone formation-related molecules in a newly established protein-independent osteosarcoma.
Yanagawa T; Watanabe H; Shinozaki T; Nakajima T; Takagishi K
Int J Oncol; 2001 Jun; 18(6):1195-205. PubMed ID: 11351251
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of bone morphogenetic protein (BMP) in osteosarcoma.
Jin Y; Yang LJ
J Oral Pathol Med; 1990 Apr; 19(4):152-4. PubMed ID: 2195159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
